Jing-Ping Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jing-Ping Wu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Jun Pu
Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
2 shared publications- Lian-Ming Wu
Department of Radiology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China
2 shared publications Yan Zhou
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
2 shared publicationsGuo-Jun Zhu
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China
1 shared publicationGuojun Zhu
Department of Radiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
1 shared publication- Jin-Yi Xiang
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 28 October 2026
- Published by Springer Nature in BMC Medical Imaging
Prognosis and risk stratification with LV global longitudinal strain and Native T1 mapping in acute myocardial infarction
- 28 October 2026
- Published by Springer Nature in BMC Medical Imaging
Open AccessPrognosis and risk stratification with LV global longitudinal strain and Native T1 mapping in acute myocardial infarction
- Open Access
- 27 August 2026
- Published by Springer Nature in Insights into Imaging
- Vol. 17 (1) , 212
A contrast-enhanced CMR-based risk score integrating microvascular obstruction and intramyocardial hemorrhage extent for prognostic evaluation
Objectives: This study aims to compare the prognostic value of the extent of microvascular obstruction (MVO) combined with intramyocardial hemorrhage (IMH) for major adverse cardiovascular events (MACE) in patients with STEMI. Materials and methods: We analyzed 568 STEMI patients in this retrospective multicenter study. Microvascular injury was visualized using late gadolinium enhancement for MVO, and T2* mapping and T2-weighted cardiovascular magnetic resonance imaging for IMH. The Youden index was used as the cutoff value to divide the study population into four groups. The Eitel CMR risk score, Glasgow CMR risk score, and GRACE (Global Registry of Acute Coronary Events) score were used as references to form Scores 1 and 2. Score 3 included LVEF ≤ 45%, MVO > 1.06% LV, IMH > 0.47% LV, and the GRACE score. Results: During a median follow-up of 3.1 years (IQR: 1.7–5.0 years), 108 patients (19%) experienced MACE. Event rates increased stepwise across groups (8.8% to 58.3%). The combination of MVO > 1.06% LV and IMH > 0.47% LV emerged as the strongest predictor of MACE (HR: 9.646, 95% CI: 6.327–14.705 [ p < 0.001]). Score 3 (integrating GRACE score, LVEF, and quantitative MVO and IMH) demonstrated improved predictive performance for MACE compared to the GRACE score (AUC: 0.748), Score 1 (AUC: 0.825), and Score 2 (AUC: 0.802), achieving an AUC of 0.853. Conclusion: Our approach integrates quantitative information on MVO and IMH into a risk score that shows better prognostic value than established risk scores. Key Points: Question Current prognostic tools for ST-elevation myocardial infarction patients lack quantitative combined assessment of microvascular obstruction and intramyocardial hemorrhage, limiting precise risk stratification after reperfusion. Findings A novel cardiac magnetic resonance score integrating quantitative microvascular obstruction and intramyocardial hemorrhage extent achieved 0.853 area under the curve for major adverse cardiovascular events. Critical Relevance Statement This study develops a quantitative cardiac magnetic resonance risk score by integrating microvascular obstruction and intramyocardial hemorrhage, offering improved prognostic value for major adverse cardiovascular events in ST-elevation myocardial infarction patients over established clinical scores.
- 27 August 2026
- Published by Springer Nature in Insights into Imaging
- Vol. 17 (1) , 212
Open AccessA contrast-enhanced CMR-based risk score integrating microvascular obstruction and intramyocardial hemorrhage extent for prognostic evaluation
Objectives: This study aims to compare the prognostic value of the extent of microvascular obstruction (MVO) combined with intramyocardial hemorrhage (IMH) for major adverse cardiovascular events (MACE) in patients with STEMI. Materials and methods: We analyzed 568 STEMI patients in this retrospective multicenter study. Microvascular injury was visualized using late gadolinium enhancement for MVO, and T2* mapping and T2-weighted cardiovascular magnetic resonance imaging for IMH. The Youden index was used as the cutoff value to divide the study population into four groups. The Eitel CMR risk score, Glasgow CMR risk score, and GRACE (Global Registry of Acute Coronary Events) score were used as references to form Scores 1 and 2. Score 3 included LVEF ≤ 45%, MVO > 1.06% LV, IMH > 0.47% LV, and the GRACE score. Results: During a median follow-up of 3.1 years (IQR: 1.7–5.0 years), 108 patients (19%) experienced MACE. Event rates increased stepwise across groups (8.8% to 58.3%). The combination of MVO > 1.06% LV and IMH > 0.47% LV emerged as the strongest predictor of MACE (HR: 9.646, 95% CI: 6.327–14.705 [ p < 0.001]). Score 3 (integrating GRACE score, LVEF, and quantitative MVO and IMH) demonstrated improved predictive performance for MACE compared to the GRACE score (AUC: 0.748), Score 1 (AUC: 0.825), and Score 2 (AUC: 0.802), achieving an AUC of 0.853. Conclusion: Our approach integrates quantitative information on MVO and IMH into a risk score that shows better prognostic value than established risk scores. Key Points: Question Current prognostic tools for ST-elevation myocardial infarction patients lack quantitative combined assessment of microvascular obstruction and intramyocardial hemorrhage, limiting precise risk stratification after reperfusion. Findings A novel cardiac magnetic resonance score integrating quantitative microvascular obstruction and intramyocardial hemorrhage extent achieved 0.853 area under the curve for major adverse cardiovascular events. Critical Relevance Statement This study develops a quantitative cardiac magnetic resonance risk score by integrating microvascular obstruction and intramyocardial hemorrhage, offering improved prognostic value for major adverse cardiovascular events in ST-elevation myocardial infarction patients over established clinical scores.
- 21 March 2026
- Published by Elsevier in European Journal of Radiology
- Vol. 199, 112789
Incremental prognostic value of left atrial strain for heart failure–related events following ST-Segment elevation myocardial infarction
- 21 March 2026
- Published by Elsevier in European Journal of Radiology
- Vol. 199, 112789
Incremental prognostic value of left atrial strain for heart failure–related events following ST-Segment elevation myocardial infarction